TrialCurrent oncology (Toronto, Ont.)2021

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).

Elisa Giommoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.